UBS Group
SMIHW

UBS Group’s Summit Healthcare Acquisition Corp. Warrant SMIHW Stock Holding History

UBS Group’s Portfolio SMIHW Stock Details SMIHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-600
Closed – – 11433
2022
Q1 		$0 Hold
600
– – ﹤0.01% 11313
2021
Q4 		$0 Buy
+600
New +$360 ﹤0.01% 11053

Other funds holding SMIHW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
OCM
Ovata Capital Management Hong Kong $715M AUM 19.57% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $976M AUM 80.85% 1-Year Est. Return

UBS Group's SMIHW Position: Q2 2022 in Review

UBS Group sold out of Summit Healthcare Acquisition Corp. Warrant (SMIHW) in Q2 2022, closing a stake of 600 shares.

UBS Group first reported a position in SMIHW in Q4 2021 and held it in 2 quarters. The position peaked at $0 in Q1 2022. 24 funds tracked by Wall St. Rank hold SMIHW as of Q2 2022.

  • UBS Group reported no remaining Summit Healthcare Acquisition Corp. Warrant position as of Q2 2022 after selling out during the quarter.
  • UBS Group sold 600 Summit Healthcare Acquisition Corp. Warrant shares in Q2 2022.
  • UBS Group first reported a position in Summit Healthcare Acquisition Corp. Warrant in Q4 2021 and held it in 2 quarters.
  • UBS Group's Summit Healthcare Acquisition Corp. Warrant position peaked at $0 in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Summit Healthcare Acquisition Corp. Warrant as of Q2 2022.

Based on UBS Group's 13F filing for Q2 2022, filed 10 Aug 2022.